Morgan Stanley’s PAVmed PAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.02K Buy
5,026
+234
+5% +$140 ﹤0.01% 7146
2025
Q1
$3.46K Hold
4,792
﹤0.01% 7074
2024
Q4
$3.01K Sell
4,792
-42
-0.9% -$26 ﹤0.01% 7117
2024
Q3
$5.95K Sell
4,834
-234
-5% -$288 ﹤0.01% 6859
2024
Q2
$4.13K Sell
5,068
-61
-1% -$50 ﹤0.01% 6898
2024
Q1
$11K Sell
5,129
-39
-0.8% -$83 ﹤0.01% 6668
2023
Q4
$21.3K Buy
5,168
+1,419
+38% +$5.85K ﹤0.01% 6639
2023
Q3
$16.6K Sell
3,749
-1,603
-30% -$7.08K ﹤0.01% 6543
2023
Q2
$32.7K Sell
5,352
-1,341
-20% -$8.2K ﹤0.01% 6374
2023
Q1
$37.5K Sell
6,693
-2,199
-25% -$12.3K ﹤0.01% 6389
2022
Q4
$64K Sell
8,892
-3,008
-25% -$21.7K ﹤0.01% 6183
2022
Q3
$154K Sell
11,900
-4,430
-27% -$57.3K ﹤0.01% 5857
2022
Q2
$229K Sell
16,330
-13,766
-46% -$193K ﹤0.01% 5829
2022
Q1
$596K Sell
30,096
-44,541
-60% -$882K ﹤0.01% 5301
2021
Q4
$2.76M Sell
74,637
-1,315
-2% -$48.5K ﹤0.01% 4311
2021
Q3
$9.73M Buy
75,952
+24,866
+49% +$3.19M ﹤0.01% 2924
2021
Q2
$4.91M Buy
51,086
+11,086
+28% +$1.06M ﹤0.01% 3797
2021
Q1
$2.66M Buy
40,000
+13,040
+48% +$868K ﹤0.01% 4037
2020
Q4
$857K Buy
26,960
+19,413
+257% +$617K ﹤0.01% 4755
2020
Q3
$202K Sell
7,547
-48
-0.6% -$1.29K ﹤0.01% 5115
2020
Q2
$240K Buy
7,595
+3,700
+95% +$117K ﹤0.01% 4988
2020
Q1
$116K Buy
+3,895
New +$116K ﹤0.01% 5127
2018
Q4
Sell
-597
Closed -$12K 6687
2018
Q3
$12K Sell
597
-133
-18% -$2.67K ﹤0.01% 6272
2018
Q2
$10K Hold
730
﹤0.01% 6309
2018
Q1
$18K Hold
730
﹤0.01% 6150
2017
Q4
$25K Buy
+730
New +$25K ﹤0.01% 6021